Replies to post #49992 on Cytodyn Inc (CYDY)

[IndexGuy]

I agree about combo. I would guess the partner isn't buying for combo but mono- which is stalled. As you said, they would have to already be in the HIV space to be interested in combo. The whole "revenue 2020" thing is about like "revenue 1H2019" to me- I just didn't believe it from the time the words left his mouth. NP indicated "the deal" is a mid-sized pharma (or did I dream that), and if that is the case, I doubt they are in HIV.

[ohm20]

The combo sale is going to be tough

Because it's better to develop resistance to all HAART drugs and develop AIDS then get a prescription for leronlimab.